Genovis Q3 2022: Solid Beat on EBIT - Redeye

Redeye leaves a more elaborate take on Genovis following its Q3 2022 report. We are left with a positive bias after yesterday's report and make minor adjustments to our forecasts, resulting in an updated fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/863455/genovis-q3-2022-solid-beat-on-ebit?utm_source=finwire&utm_medium=RSS